IFITM1 and neoplasm: In this study, we observed that IFITM1 silencing significantly decreased the protein levels of β-catenin, cyclin D1, and c-Myc in lung cancer cells and tumor tissues, indicating an inhibitory effect of IFITM1 silencing on the Wnt/β-catenin signaling pathway.